Company Filing History:
Years Active: 1992
Title: David M Nanus: Innovator in Cancer Research
Introduction
David M Nanus is a prominent inventor based in New Rochelle, NY (US). He has made significant contributions to the field of cancer research, particularly in the detection of sensitivity to alpha-interferon therapy. His innovative approach has the potential to enhance treatment outcomes for patients undergoing this therapy.
Latest Patents
David M Nanus holds a patent for a method to detect sensitivity to alpha-interferon therapy. This invention provides a method of detecting sensitivity by contacting a sample with a monoclonal antibody under conditions that allow for the formation of an antibody-antigen complex. The detection of this complex enables the assessment of sensitivity to alpha-interferon, which is crucial for tailoring effective treatment plans. He has 1 patent to his name.
Career Highlights
David M Nanus is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance his research in oncology. His work is instrumental in developing methods that improve patient care and treatment efficacy.
Collaborations
Throughout his career, David has collaborated with notable colleagues, including Anthony P Albino and Neil H Bander. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer treatment.
Conclusion
David M Nanus exemplifies the spirit of innovation in cancer research through his patented methods and collaborative efforts. His contributions are vital in the ongoing quest to improve cancer therapies and patient outcomes.